Outlook Therapeutics
OTLK
#9640
Rank
โ‚น3.83 B
Marketcap
โ‚น119.91
Share price
8.53%
Change (1 day)
-84.65%
Change (1 year)

Revenue for Outlook Therapeutics (OTLK)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Outlook Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A-100%
2019 โ‚น0.50 B113.38%
2018 โ‚น0.23 B-13.44%
2017 โ‚น0.27 B75.79%
2016 โ‚น0.15 B-28.67%
2015 โ‚น0.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น51.83 BN/A Jersey
โ‚น58.42 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.44 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.87 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK